Loading...
Quest Diagnostics Incorporated
DGX•NYSE
Healthcare
Medical - Diagnostics & Research
$177.83
$0.77(0.43%)
Quest Diagnostics Incorporated (DGX) Financial Performance & Statements
Review Quest Diagnostics Incorporated’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.70%
↑ 6.70%
Operating Income Growth
6.66%
↑ 6.66%
Net Income Growth
1.99%
↑ 1.99%
Operating Cash Flow Growth
4.87%
↑ 4.87%
Operating Margin
13.85%
↑ 13.85%
Gross Margin
32.57%
↑ 32.57%
Net Profit Margin
8.83%
↑ 8.83%
ROE
13.22%
↑ 13.22%
ROIC
9.80%
↑ 9.80%
Quest Diagnostics Incorporated (DGX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Quest Diagnostics Incorporated stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.62B | $2.49B | $2.40B | $2.37B |
| Cost of Revenue | $1.76B | $1.68B | $1.62B | $1.61B |
| Gross Profit | $858.00M | $811.00M | $776.00M | $755.00M |
| Gross Profit Ratio | $0.33 | $0.33 | $0.32 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $466.00M | $448.00M | $406.00M | $436.00M |
| Operating Expenses | $497.00M | $481.00M | $406.00M | $436.00M |
| Total Costs & Expenses | $2.26B | $2.16B | $2.03B | $2.05B |
| Interest Income | $7.00M | $9.00M | $3.00M | $6.00M |
| Interest Expense | $72.00M | $58.00M | $47.00M | $49.00M |
| Depreciation & Amortization | $135.00M | $125.00M | $117.00M | $116.00M |
| EBITDA | $507.00M | $479.00M | $478.00M | $431.00M |
| EBITDA Ratio | $0.19 | $0.19 | $0.20 | $0.18 |
| Operating Income | $361.00M | $330.00M | $370.00M | $319.00M |
| Operating Income Ratio | $0.14 | $0.13 | $0.15 | $0.13 |
| Other Income/Expenses (Net) | -$62.00M | -$34.00M | -$41.00M | -$53.00M |
| Income Before Tax | $299.00M | $296.00M | $314.00M | $266.00M |
| Income Before Tax Ratio | $0.11 | $0.12 | $0.13 | $0.11 |
| Income Tax Expense | $68.00M | $65.00M | $74.00M | $66.00M |
| Net Income | $222.00M | $226.00M | $229.00M | $194.00M |
| Net Income Ratio | $0.08 | $0.09 | $0.10 | $0.08 |
| EPS | $1.98 | $2.01 | $2.05 | $1.74 |
| Diluted EPS | $1.95 | $1.99 | $2.04 | $1.72 |
| Weighted Avg Shares Outstanding | $111.00M | $112.00M | $111.00M | $111.00M |
| Weighted Avg Shares Outstanding (Diluted) | $113.00M | $113.00M | $112.00M | $112.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan